We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+16.69%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$176M
AUM Growth
+$30.3M
(+21%)
Cap. Flow
+$13.4M
Cap. Flow
% of AUM
7.61%
Top 10 Holdings %
Top 10 Hldgs %
46.67%
Holding
67
New
5
Increased
34
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veracyte
VCYT
|
+$3.07M |
| 2 |
Vanda Pharmaceuticals
VNDA
|
+$2.72M |
| 3 |
AtriCure
ATRC
|
+$2.39M |
| 4 |
AngioDynamics
ANGO
|
+$2.11M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$2.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TLGT
Teligent, Inc
TLGT
|
+$4.59M |
| 2 |
Sanofi
SNY
|
+$2.13M |
| 3 |
ABCO
Advisory Board Co
ABCO
|
+$1.69M |
| 4 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
+$1.4M |
| 5 |
SGNT
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
|
+$806K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.57% |
| 2 | Consumer Staples | 0.89% |
| 3 | Financials | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
51
DELISTED
Aetna Inc
AET
| $463K | 0.26% |
5,215
| – | – |
|
|
CFN
52
DELISTED
CAREFUSION CORPORATION
CFN
| $459K | 0.26% |
7,730
| – | – |
|
53
Steris
STE
$22.3B
| $411K | 0.23% |
6,330
| – | – |
|
54
AstraZeneca
AZN
$263B
| $400K | 0.23% |
5,680
| – | – |
|
55
Johnson & Johnson
JNJ
$618B
| $399K | 0.23% |
3,820
| – | – |
|
|
STJ
56
DELISTED
St Jude Medical
STJ
| $394K | 0.22% |
6,055
| – | – |
|
57
Becton Dickinson
BDX
$45.6B
| $389K | 0.22% |
2,865
| – | – |
|
58
Eli Lilly
LLY
$1.02T
| $379K | 0.21% |
5,495
| – | – |
|
59
Merck
MRK
$322B
| $375K | 0.21% |
6,927
| – | – |
|
60
Amgen
AMGN
$208B
| $371K | 0.21% |
2,330
| – | – |
|
61
Community Health Systems
CYH
$393M
| $331K | 0.19% |
7,435
| – | – |
|
62
Pfizer
PFE
$143B
| $328K | 0.19% |
11,088
| – | – |
|
63
Myriad Genetics
MYGN
$270M
| $266K | 0.15% |
7,820
| – | – |
|
|
64
Sanofi
SNY
$103B
| $259K | 0.15% |
5,680
-43,953
| -89% | -$2.13M |
|
65
Agilent Technologies
A
$39.1B
| $210K | 0.12% |
5,120
-2,038
| -28% | -$82.2K |
|
66
Bio-Rad Laboratories Class A
BIO
$8.71B
| $202K | 0.11% |
+1,675
| New | +$193K |
|
|
ABCO
67
DELISTED
Advisory Board Co
ABCO
| – | – |
-36,226
| Closed | -$1.69M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, First Light Asset Management held 67 positions worth $176M, up 21% from $146M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
First Light Asset Management deployed $13.4M of net new capital in Q4 2014, opening 5 new positions and adding to 34 existing holdings. Its largest new stake was Veracyte: 393,926 shares worth $3.81M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier, followed by Consumer Staples and Financials.
On the sell side, the largest reduction was Teligent, Inc, an estimated $4.59M trimmed.
- First Light Asset Management's largest Q4 2014 buy was Veracyte: 393,926 shares worth $3.81M.
- First Light Asset Management added most to AtriCure in Q4 2014, an estimated $2.39M increase.
- First Light Asset Management's biggest Q4 2014 reduction was Teligent, Inc, cutting an estimated $4.59M.
- First Light Asset Management fully exited Advisory Board Co in Q4 2014, selling an estimated $1.69M.
- First Light Asset Management's ten largest holdings make up 47% of its $176M portfolio in Q4 2014.
- First Light Asset Management opened 5 new positions and closed 1 in Q4 2014.
- First Light Asset Management's portfolio value rose 21% quarter-over-quarter to $176M.
Based on First Light Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.